14 Aug, EOD - Indian

Nifty Next 50 66511.6 (-0.17)

SENSEX 80597.66 (0.07)

Nifty Bank 55341.85 (0.29)

Nifty Midcap 100 56504.25 (-0.31)

Nifty Pharma 22151.85 (0.10)

Nifty IT 34833.2 (0.40)

Nifty 50 24631.3 (0.05)

Nifty Smallcap 100 17547.45 (-0.38)

14 Aug, EOD - Global

NIKKEI 225 43378.31 (1.71)

HANG SENG 25270.07 (-0.98)

S&P 6483.5 (-0.29)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoSunrest Lifescience Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 91669 | NSE Symbol : SUNREST | ISIN : INE0PLZ01012 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
01-Aug-2025 01-Aug-2025 Change in Registered Address Sunrest Lifescience Limited has informed the Exchange regarding Board meeting held on August 01, 2025.
13-May-2025 30-May-2025 Accounts To consider and approve the financial results for the period ended March 31, 2025 SUNREST : 30-May-2025 : The Company has informed the Exchange that a Board meeting to be held on May 27, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2025, To consider and approve the financial results for the period ended March 31, 2025 (As Per NSE Announcement Dated on : 27.05.2025) Sunrest Lifescience Limited has informed the Exchange regarding Board meeting held on May 30, 2025. (As Per NSE Announcement Dated On : 30.05.2025)
26-Mar-2025 26-Mar-2025 Others Sunrest Lifescience Limited has informed the Exchange regarding Board meeting held on March 26, 2025.
24-Mar-2025 24-Mar-2025 Change in Other Executives Sunrest Lifescience Limited has informed the Exchange regarding Board meeting held on March 24, 2025
24-Dec-2024 24-Dec-2024 Change in Other Executives To take a note on the Resignation of Ms. Nishi Shah as the Company Secretary and Compliance officer of the Company from close of business hour on December 17th, 2024.
06-Nov-2024 14-Nov-2024 Quarterly Results To consider and approve the financial results for the period ended September 30, 2024 Sunrest Lifescience Limited has informed the Exchange regarding Board meeting held on November 14, 2024. (As Per NSE Announcement Dated on: 14/11/2024)
17-Jun-2024 17-Jun-2024 Change in Auditors Appointment of Secretarial Auditor and Internal Auditor for the FY 2024 - 25
17-May-2024 27-May-2024 Accounts To consider and approve the financial results for the period ended March 31, 2024 Sunrest Lifescience Limited has informed the Exchange regarding Board meeting held on May 27, 2024 Where the Board of Directors have Considered and approved Standalone Audited Financial Results of the company for the half year and year ended 31st March, 2024. (As Per BSE Announcement dated On: 27/05/2024)
21-Mar-2024 21-Mar-2024 Others Consent of the Board of directors of the Company is hereby accorded to dispose of 11,000 equity shares of Rs. 10 each of the company TRILEND PHARMACEUTICALS PRIVATE LIMITED (CIN: U24100GJ2019PTC106321) held as an Investment.
07-Feb-2024 07-Feb-2024 Others To appoint Asnani Stock Broker Private Limited (Member of BSE, NSE, CDSL, MCX, NCDEX) having SEBI Registration No INZ000190431 as an Additional Market Maker of the Company
17-Jan-2024 23-Jan-2024 Quarterly Results To consider and approve the financial results for the period ended September 30, 2023, Appointment of Secretarial Auditor and Appointment of Internal Auditor of the Company. 1. Considered and approved Standalone Unaudited Financial Results along with Limited Review Report of the company for the half year ended 30th September, 2023.2. Mr. Jinang Dineshkumar Shah, a Practicing Company Secretary, Proprietor of M/S Jinang Shah & Associates is hereby appointed for conducting a secretarial audit of the company for the Financial year 2023-24 w.e.f 23.01.2024.3. Mr. Birjesh H. Vithalani, Partner at VRCA & Associates is hereby appointed as an Internal Auditor of the Company for the Financial Year 2023, 24 w.e.f 23.01.2024. (As Per NSE Announcement Dated on: 23/01/2024)
1 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-8657545825
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
subscription@capitalmarket.com

For Capital Market Online Product related queries :
financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +